To analyze the development trend of the prevention and control of thalassemia in China from the perspective of bibliometrics, and to provide reference for future research and prevention and control of thalassemia. The literatures on the prevention and control of thalassemia in China from January 1, 1986 to October 25, 2025 were collected from China National Knowledge Infrastructure (CNKI) database. The bibliometrics and visualization methods were used to organize and analyze the number of papers, authors, institutions, keywords, etc. A total of 4409 articles were included in this study. The number of published articles increased slowly in the early stage, surged in the middle stage, reached a peak in 2019, and then gradually decreased. The author with the largest number of publications was He Sheng from Guangxi Maternal and Child Health Hospital (44 articles). The main research sites are concentrated in Guangdong and Guangxi, forming a research pattern characterized by concentration in South China and dispersion across the country. The top three key words were "thalassemia", "iron deficiency anemia" and "prenatal diagnosis". The research focus has shifted from the basic diagnosis of the disease to the popularization of diagnostic techniques in primary care. The research on prevention and control of thalassemia in China is at the early stage of maturity. The core research strength is concentrated in South China, and the regional distribution is uneven. The cooperation ability of researchers needs to be improved.

Qixian Huang, Xin Peng. Bibliometric Study on Prevention and Control of Thalassemia in China Based on Citespace. Academic Journal of Medicine & Health Sciences (2026), Vol. 7, Issue 1: 25-32. https://doi.org/10.25236/AJMHS.2026.070104.

[1] KATTAMIS A, KWIATKOWSKI J L, AYDINOK Y. Thalassaemia [J]. Lancet, 2022, 399(10343): 2310-24.

[2] WANG W D, HU F, ZHOU D H, et al. Thalassaemia in China [J]. Blood Rev, 2023, 60: 101074.

[3] ZHEN X, MING J, ZHANG R, et al. Economic burden of adult patients with beta-thalassaemia major in mainland China [J]. Orphanet J Rare Dis, 2023, 18(1): 252.

[4] CAO A, KAN Y W. The prevention of thalassemia [J]. Cold Spring Harb Perspect Med, 2013, 3(2): a011775.

[5] LI Q, LI X, HE S, et al. Hotspots and status of Fetal Alpha-Thalassemia from 2009 to 2023: a bibliometric analysis [J]. Front Pediatr, 2024, 12: 1467760.

[6] LV A, LI J, CHEN M, et al. Global Trends on beta-Thalassemia Research Over 10 Years: A Bibliometric Analysis [J]. Int J Gen Med, 2024, 17: 3989-4001.

[7] LAI K, HUANG G, SU L, et al. The prevalence of thalassemia in mainland China: evidence from epidemiological surveys [J]. Sci Rep, 2017, 7(1): 920.

[8] WEI B, ZHOU W, PENG M, et al. The population incidence of thalassemia gene variants in Baise, Guangxi, P. R. China, based on random samples [J]. Hematology, 2022, 27(1): 1026-31.

[9] Jiang HS, Peng Y. Expert Consensus on Screening and Prevention and Control of Thalassemia Carriers in China [J]. Journal of International Neurology and Neurosurgery, 2024, 51 (5):43-50. DOI: 10.16636/j.cnki.jinn.1673-2642.2024.05.006.

[10] Wu J, Zeng HY. Application of hematological analysis combined with gene diagnosis in prenatal diagnosis of thalassemia [J]. International Journal of Laboratory Medicine, 2015, 36 (5):604-605, 607.